Levodopa/Carbidopa Orion [Carbidopa/Levodopa Orion]

Medicinal product

(Invented) name

Active substance (s)

Levodopa/Karbidopa

Strength

250 mg/25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

Orion Corporation, Suomija

Date of authorisation

2024-06-17

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

FI/H/1142/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Levodopa	250 mg
Karbidopa	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113915	100032	1100032	buteliukas	N100		Receptinis	LT/1/24/5468/001	Tiekiama	2025-09-02	-	No	-	-

Stadijos

Data	Stadija
2024-06-17	Registruotas